@article{LCBL45392,
author = {Haruhiko Sugimura},
title = {Are there markers for exceptional responders available for attending pathologists?},
journal = {临床与病理杂志},
volume = {41},
number = {11},
year = {2021},
keywords = {},
abstract = {In the records of the recent rampant clinical trials, people have noticed there is a fraction, though small, who have extremely good responses to the drugs. The definition of this population “Cancer exceptional responder” is proposed and feasibility study has been launched.},
url = {https://lcbl.amegroups.com/article/view/45392}
}